First Shanghai Investments Limited (0227) AI Stock Analysis

• Market Cap: €755.78M
• Dividend Yield: N/A
• Average Volume (3M): 5.64M
• Price to Earnings (P/E): 49.3
• Beta (1Y): 3.54
• Revenue Growth: 3.07%
• EPS Growth: -72.40%
• Country: HK
• Employees: 569
• Sector: Financial
• Sector Strength: 70
• Industry: Financial - Capital Markets
• EPS (TTM): <0.01
• Shares Outstanding: 2,190,680,000
• 10 Day Avg. Volume: 3,232,640
• 30 Day Avg. Volume: 5,638,539
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: €0.46
• Price Target Upside: 35.11% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 1

• Rating: 50 Neutral
• Price Target: HK$0.50 ▲(47.06% Upside)

The overall stock score is primarily influenced by financial performance and technical analysis. While the company shows positive revenue growth and improved profitability, concerns about cash flow generation and a high P/E ratio weigh down the score. Technical indicators suggest weak momentum, contributing to a cautious outlook.

First Shanghai Investments Limited Business Overview & Revenue Model

Company Description

First Shanghai Investments Limited, an investment holding company, engages in financial services, property and hotel, medical and healthcare, and direct investment sectors in Hong Kong, the People's Republic of China, and internationally. The company offers securities investment, securities broking, margin financing, corporate finance, underwriting and placements, asset management, wealth management, shares placement, IPO subscription, shares custodian, nominee, financial intermediary, and investment advisory services. It also develops residential, service apartment, commercial office, industrial office, hotel, and recreation resort properties; develops and commercializes therapeutic drugs; and provides container transportation and freight forwarding services. In addition, the company operates a medical center in Central, Hong Kong that provides medical and healthcare services, including imaging, day surgery, endoscopy, and check-up services, as well as medical beauty treatments, and general and specialist consultation services. Further, it provides money lending, nominee, agency, management and secretarial, financial leasing and consultancy, internet financial service system, dental, futures broking, stock broking, insurance broking, and property investment services, as well as operates hotel and golf course. The company was formerly known as Public International Investments Limited and changed its name to First Shanghai Investments Limited in June 1993. First Shanghai Investments Limited was founded in 1964 and is based in Central, Hong Kong.

How the Company Makes Money

First Shanghai Investments Limited generates revenue through multiple channels. In financial services, the company earns income from brokerage fees, advisory fees in corporate finance, and management fees from asset management services. The property development segment contributes through the sale and leasing of residential, commercial, and industrial properties. Additionally, the company engages in direct investments, where it seeks capital appreciation and income through strategic investments in various industries. Strategic partnerships and joint ventures also play a significant role in enhancing its revenue streams by leveraging shared expertise and resources.

First Shanghai Investments Limited Financial Statement Overview

Summary

First Shanghai Investments Limited showed positive revenue growth and improved profitability in 2024. The balance sheet reflects increased financial stability with a lower debt burden and positive ROE. However, significant concerns exist around cash flow generation and management, which could pose risks if not addressed.

Income Statement

The company experienced a revenue growth rate of 15.7% in 2024, indicating a positive trend. The gross profit margin remained strong at 100%, but the net profit margin improved significantly from the previous year's negative margin to 21.5%. However, EBIT and EBITDA margins were weak, with EBIT margin at 7.2% and EBITDA margin unavailable due to missing data.

Balance Sheet

The debt-to-equity ratio decreased substantially, reflecting improved financial stability. The return on equity (ROE) turned positive in 2024, reaching 3.13%, which is a significant improvement. The equity ratio remained stable, indicating a balanced capital structure.

Cash Flow

The free cash flow growth rate was not calculable due to missing free cash flow data. The company faced challenges in generating operating cash flow, as evidenced by the operating cash flow to net income ratio being unavailable. This indicates potential issues in cash flow generation and management.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	390.39M	312.88M	342.18M	529.85M	457.99M
Gross Profit	219.88M	207.43M	210.34M	303.46M	258.47M
EBITDA	152.83M	-16.88M	-23.95M	48.21M	53.18M
Net Income	77.97M	-10.63M	-58.84M	-149.00M	-90.82M
Balance Sheet
Total Assets	5.05B	5.62B	5.90B	7.11B	6.74B
Cash, Cash Equivalents and Short-Term Investments	283.49M	334.67M	241.86M	325.49M	325.86M
Total Debt	120.44M	213.74M	264.47M	333.84M	575.73M
Total Liabilities	2.49B	3.19B	3.52B	4.55B	4.05B
Stockholders Equity	2.49B	2.37B	2.32B	2.48B	2.61B
Cash Flow
Free Cash Flow	-92.73M	1.43M	-75.88M	-3.70M	9.21M
Operating Cash Flow	-83.35M	6.01M	-66.51M	3.66M	28.62M
Investing Cash Flow	139.84M	114.89M	86.71M	49.27M	224.06M
Financing Cash Flow	-110.80M	-24.94M	-92.35M	-44.91M	-151.68M

First Shanghai Investments Limited Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.34
• 50DMA: Negative
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:0227, the sentiment is Negative. The current price of 0.34 is below the 20-day moving average (MA) of 0.37, below the 50-day MA of 0.40, and above the 200-day MA of 0.30, indicating a neutral trend. The MACD of -0.01 indicates Positive momentum. The RSI at 39.10 is Neutral, neither overbought nor oversold. The STOCH value of 30.95 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:0227.

First Shanghai Investments Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
0717	69 Neutral	876.31M	10.25	1.92%	―	-4.56%	0.00%
1461	54 Neutral	801.52M	20.41	0.00%	1.91%	-18.71%	-45.10%
1141	54 Neutral	1.04B	12.10	0.00%	―	126.33%	0.00%
0218	53 Neutral	3.04B	-45.68	-6.11%	―	-45.13%	60.10%
0227	50 Neutral	€755.78M	49.28	0.63%	―	3.07%	-72.40%
0952	45 Neutral	977.19M	-11.35	-3.68%	―	173.24%	-515.63%
Sector *	68 Neutral	$18.00B	11.42	9.92%	3.81%	9.73%	1.22%

First Shanghai Investments Limited Corporate Events

First Shanghai Investments Reports Mixed Interim Results for 2025

First Shanghai Investments Limited reported its unaudited interim results for the six months ending June 30, 2025. The company experienced a decline in revenue from HK$208.7 million in 2024 to HK$191.6 million in 2025, leading to a drop in profit attributable to shareholders from HK$66.3 million to HK$3.3 million. Despite the decrease in profit, the company saw a significant increase in other comprehensive income, resulting in a total comprehensive income of HK$57.9 million, up from HK$28.1 million in the previous year. This indicates a mixed performance with challenges in operational profitability but improvements in other financial metrics.

The most recent analyst rating on (HK:0227) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on First Shanghai Investments Limited stock, see the HK:0227 Stock Forecast page.

First Shanghai Investments to Review Interim Results and Dividend Declaration

First Shanghai Investments Limited has announced a Board of Directors meeting scheduled for August 22, 2025, to review and approve the interim results for the first half of the year ending June 30, 2025. The meeting will also consider the declaration of an interim dividend, which could impact the company’s financial strategy and shareholder returns.